Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by HENWOOD GERALDINE

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
BXRXBaudax Bio, Inc.HENWOOD GERALDINEPresident and CEODec 15, 2022Buy$2.551,2003,0572,427Dec 19, 2022, 08:09 AM
BXRXBaudax Bio, Inc.HENWOOD GERALDINEPresident and CEODec 15, 2021Option Exercise$0.3118,6365,777336,716Dec 23, 2021, 05:45 PM
BXRXBaudax Bio, Inc.HENWOOD GERALDINEPresident and CEODec 05, 2021Option Exercise$0.359,1553,204355,352Dec 14, 2021, 06:27 PM
BXRXBaudax Bio, Inc.HENWOOD GERALDINEPresident and CEOSep 22, 2021Buy$0.598,2004,798364,507Sep 23, 2021, 04:10 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEDirectorJan 18, 2021Option Exercise$3.036,81620,652199,651Jan 20, 2021, 07:54 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEDirectorJan 02, 2021Option Exercise$3.095,59917,301201,467Jan 05, 2021, 05:04 PM
BXRXBaudax Bio, Inc.HENWOOD GERALDINEPresident and CEODec 05, 2020Option Exercise$1.1483,01594,637356,155Dec 09, 2020, 05:45 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEPresident and CEODec 05, 2020Option Exercise$2.3034,12878,494207,066Dec 09, 2020, 05:43 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEPresident and CEOApr 17, 2020Sale$5.35160,000855,200321,194Apr 20, 2020, 07:42 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEPresident and CEOApr 17, 2020Sale$8.2280,000657,600161,194Apr 20, 2020, 04:32 PM
BXRXBaudax Bio, Inc.HENWOOD GERALDINEPresident and CEOJan 27, 2020Option Exercise$8.515,05142,984367,887Jan 29, 2020, 07:44 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEPresident and CEOJan 18, 2020Option Exercise$16.385,55290,942241,194Jan 22, 2020, 05:44 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEPresident and CEOJan 02, 2020Option Exercise$17.534,94586,686241,746Jan 03, 2020, 04:51 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEPresident and CEOMay 13, 2019Sale$5.93268,3061,592,341342,947May 15, 2019, 04:06 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEPresident and CEOJan 18, 2019Option Exercise$7.991,42511,386219,447Feb 19, 2019, 04:11 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEPresident and CEOJan 18, 2019Option Exercise$7.991,42511,386214,384Jan 23, 2019, 04:08 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEPresident and CEOJan 02, 2019Option Exercise$7.414,22331,292175,008Jan 04, 2019, 05:37 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEPresident and CEOJan 02, 2019Option Exercise$7.414,22331,292175,008Jan 04, 2019, 04:40 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEPresident and CEOJan 18, 2018Option Exercise$8.891,57514,002179,231Jan 22, 2018, 05:25 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEPresident and CEOSep 28, 2017Option Exercise$9.049,79488,538125,806Oct 02, 2017, 06:41 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEPresident and CEOJun 05, 2015Buy$8.833,95034,878103,950Jun 09, 2015, 12:33 PM
REPHRecro Pharma, Inc.HENWOOD GERALDINEPresident and CEOJun 08, 2015Buy$9.565505,258104,500Jun 09, 2015, 12:33 PM
ALKSAlkermes plc.HENWOOD GERALDINEDirectorJan 15, 2014Sale$31.4980,0002,518,96540,000Jan 17, 2014, 05:11 PM
ALKSAlkermes plc.HENWOOD GERALDINEDirectorAug 29, 2013Sale$22.5640,000902,33220,000Aug 30, 2013, 05:15 PM
MAPPMAP Pharmaceuticals, Inc.HENWOOD GERALDINEDirectorFeb 28, 2013Option Exercise$18.5320,000370,65010,000Mar 04, 2013, 07:40 PM
MAPPMAP Pharmaceuticals, Inc.HENWOOD GERALDINEDirectorNov 23, 2012Sale$8.7410,48091,6283,750Nov 27, 2012, 02:38 PM
ALKSAlkermes plc.HENWOOD GERALDINEDirectorAug 24, 2012Sale$14.8940,000595,64220,000Aug 28, 2012, 05:12 PM
ALKSAlkermes plc.HENWOOD GERALDINEDirectorAug 27, 2012Sale$14.6240,000584,79020,000Aug 28, 2012, 05:12 PM
ALKSAlkermes plc.HENWOOD GERALDINEDirectorFeb 23, 2012Sale$13.153,20042,0721,600Feb 23, 2012, 04:10 PM
ALKSAlkermes plc.HENWOOD GERALDINEDirectorFeb 22, 2012Option Exercise$13.4192,8001,244,80120,000Feb 23, 2012, 04:10 PM
MAPPMAP Pharmaceuticals, Inc.HENWOOD GERALDINEDirectorOct 27, 2010Option Exercise$8.6619,528169,1274,387Oct 29, 2010, 05:32 PM
MAPPMAP Pharmaceuticals, Inc.HENWOOD GERALDINEDirectorAug 05, 2010Option Exercise$6.7624,000162,32812,000Aug 06, 2010, 05:12 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe